Probiotics in Mild Alzheimer's Disease
Recruiting
Early Phase 1
Interventional Study
Neurodegenerative Diseases
Cognition Disorders in Old Age
At a Glance
- Age
- 65 – 85
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- University of Nicosia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objective is to investigate whether administration of probiotics to patients with mild Alzheimer's Disease (AD) reduces neuroinflammation, improves cognitive function and modifies neurophysiological measures, compared to a patient group that receives placebo (no active probiotics).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults ≥65 years, able to give consent
* Mini-Mental State Examination (MMSE) scores 19-23 (mild AD)
* approximately equal male:female ratio
Exclusion Criteria:
* Inability to give consent
* other neurological disease
* relevant psychiatric disorders (e.g. major depression)
…
Contacts